Hollis-eden Pharmaceuticals, Inc (HEPH)
Contact Information:
| Business Address: | - |
| Mailing Address: | 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122 Business Address 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122 858-587-9333 |
| Phone: | 858-587-9333 |
| Fax: | 858-558-6470 |
| Website: | http://www.holliseden.com |
Company Details:
| Symbol: | HEPH |
| SIC: | - |
| State location: | CA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 42 |
| Type: | NASDAQ |
Key executives:
| Name | Age | Position |
|---|---|---|
| Christopher L. Reading Ph.D. | 64 | Exec. VP of Scientific Devel. |
| Daniel D. Burgess | 50 | Chief Operating Officer and Chief Financial Officer |
| Eric J. Loumeau | 49 | VP and Corp. Gen. Counsel |
| James M. Frincke Ph.D. | 61 | Chief Scientific Officer |
| Richard B. Hollis | 59 | Founder, Chairman, Chief Exec. Officer and Pres |
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| 1 | The latest news of the company are... | 0 | Rosheen | July 29, 2008, 02:06AM |
| 2 | Here on this message board we are inviting... | 0 | Guest | July 29, 2008, 02:06AM |

